Pediatrics (System-Integrated)
Down syndrome: surveillance and primary care
— Nondisjunction (~95%): maternal meiotic error; risk rises sharply with maternal age (1/1500 at age 20, 1/100 at age 40).
— Robertsonian translocation (~3–4%): typically der(14;21); recurrence risk is substantial if a parent is a balanced carrier (10–15% if maternal carrier, ~1% if paternal).
— Mosaicism (~1–2%): variable phenotype; do not assume milder cognitive outcomes.
— Hypotonia, flat facies, upslanting palpebral fissures, epicanthal folds, small ears, single transverse palmar crease, sandal-toe gap, brachycephaly, brushfield spots, redundant nuchal skin, poor Moro reflex.
— Feeding difficulty, delayed meconium passage (consider Hirschsprung), bilious emesis (duodenal atresia/annular pancreas).
— First-trimester combined screen (NT + PAPP-A + β-hCG), quad screen (↓AFP, ↓estriol, ↑hCG, ↑inhibin A), and cell-free fetal DNA (cfDNA) — highest sensitivity/specificity noninvasive option.
— Confirmation requires karyotype via CVS (10–13 wk) or amniocentesis (≥15 wk).

— Hypotonia ("floppy infant"), poor suck, prolonged jaundice, polycythemia, transient abnormal myelopoiesis (TAM) in ~10%.
— Congenital heart disease in ~50% (most commonly AV septal defect/AVSD, then VSD, ASD, tetralogy of Fallot).
— GI anomalies: duodenal atresia ("double bubble"), annular pancreas, imperforate anus, Hirschsprung disease, TEF.
— Global developmental delay; gross motor most delayed (walking ~24 mo).
— Recurrent otitis media → conductive hearing loss; OSA emerges by age 3–4.
— Failure to thrive vs. later obesity risk; constipation common.
— Mild–moderate intellectual disability (mean IQ 40–70).
— Atlantoaxial instability concerns with sports participation.
— Behavioral: ADHD, anxiety, oppositional behavior; autism spectrum disorder co-occurs in ~15–20%.
— Delayed puberty in males, near-normal in females; men are typically infertile, women are subfertile with 50% chance of transmitting T21.
— Obesity, OSA, depression, celiac disease, thyroid dysfunction.
— Early-onset Alzheimer disease (clinical dementia typically begins in 40s–50s due to triplicated APP gene on chr 21).
— Increased risk of leukemia (ALL and AMKL), reduced risk of most solid tumors.

— Listen for holosystolic murmur (VSD, AVSD regurg), fixed split S2 (ASD), single S2 (pulmonary HTN), gallop.
— AVSD may be deceptively quiet in the neonate because pulmonary vascular resistance is still high; the absence of a murmur does not rule out CHD.
— Assess perfusion, hepatomegaly, tachypnea, growth velocity — signs of CHF from left-to-right shunt typically appear at 4–8 weeks as PVR drops.

— Send karyotype (cytogenetic analysis) on every newborn with suspected T21 — distinguishes nondisjunction, translocation, and mosaicism; this distinction drives recurrence-risk counseling.
— FISH or chromosomal microarray can give rapid preliminary results but karyotype remains the standard.
— Echocardiogram by pediatric cardiology within first month.
— CBC with differential at birth: screen for polycythemia (Hct >65% → partial exchange if symptomatic), leukocytosis, blasts (transient abnormal myelopoiesis).
— TSH as part of state newborn screen, then repeat at 6 and 12 months and annually thereafter (high rate of congenital and acquired hypothyroidism).
— Newborn hearing screen (ABR preferred over OAE) — high false-negative rate with OAE due to narrow canals.
— Red reflex and ophthalmology referral by 6 months for congenital cataract and strabismus.
— Feeding/swallow evaluation if any feeding difficulty or aspiration risk.
— Abdominal x-ray if bilious emesis or no meconium in 48 hours → "double bubble" → surgical consult.
— Contrast enema/rectal suction biopsy if delayed stool, distention → Hirschsprung.
— Do NOT order routine cervical spine films in asymptomatic infants. AAP no longer recommends routine screening films; image only if neurologic symptoms or before high-risk activities (e.g., Special Olympics in some programs).

— CBC at birth (TAM), then again to monitor; lifetime risk of ALL ~1% and AMKL ~500× general population, especially under age 5.
— Any unexplained bruising, pallor, fatigue, or hepatosplenomegaly → CBC and peripheral smear urgently.
— TSH at birth, 6 mo, 12 mo, then annually for life. Free T4 if TSH abnormal. Anti-TPO if acquired autoimmune hypothyroidism suspected.
— Newborn ABR; behavioral audiometry every 6 months until age 4, then annually. Tympanograms often abnormal due to chronic effusion → ENT referral, possible tubes.
— Ophtho exam by 6 months, then every 1–2 years; watch for keratoconus in adolescence.
— Polysomnogram by age 4 for all children regardless of symptoms (OSA prevalence 50–80%, parent report unreliable).
— Screen with tissue transglutaminase IgA + total IgA when symptomatic (failure to thrive, diarrhea, constipation, anemia, behavior change). Routine universal screening of asymptomatic children is debated; AAP suggests symptom-driven testing.
— Targeted history and neuro exam at every well visit; imaging only if symptoms (neck pain, torticollis, gait change, weakness, bowel/bladder dysfunction, hyperreflexia).
— Annual TSH, CBC, lipid panel; weight/BMI; depression and dementia screening using baseline cognitive assessment in early adulthood as a comparator.

— Anchor on the AAP Health Supervision for Children and Adolescents with Down Syndrome guideline (2022 update).
— At each well visit: review growth on Down syndrome–specific growth charts (CDC 2015), update surveillance labs, screen for behavioral and developmental concerns, address family supports.
— 0–1 mo: confirm diagnosis, echo, CBC, TSH, hearing, red reflex, feeding, genetics.
— 1–12 mo: echo follow-up, repeat TSH (6, 12 mo), ophtho by 6 mo, audiology by 6 mo, early intervention enrollment.
— 1–5 yr: annual TSH/CBC, audiology every 6 mo, ophtho yearly, PSG by age 4, dental every 6 mo from age 2, celiac if symptomatic.
— 5–13 yr: annual TSH, CBC, audiology, ophtho every 1–2 yr, behavior/mental health screen, school IEP support, transition to MyPlate/active lifestyle counseling.
— 13–21 yr: annual TSH, lipid panel at 20, mental health, OSA reassessment, reproductive health and consent capacity discussion, transition planning to adult care by age 14.
— Adult: annual TSH, CBC, lipid, depression, dementia surveillance, OSA reassessment, vision/hearing yearly.
— AVSD repair patients → endocarditis prophylaxis only for first 6 months post-repair or if residual defect.
— Children with severe OSA → cardiac re-evaluation for pulmonary HTN.

— Treat congenital hypothyroidism with levothyroxine 10–15 mcg/kg/day; titrate to TSH and free T4 with repeat labs in 2–4 weeks.
— In acquired hypothyroidism, start lower (~25–50 mcg/day in older children) and titrate.
— Diuretics (furosemide ± spironolactone), high-calorie formula for growth, sometimes ACE inhibitor; refer for surgical repair of AVSD ideally by 3–6 months of age to prevent irreversible pulmonary vascular disease.
— First line is adenotonsillectomy; CPAP if residual; weight management; consider hypoglossal nerve stimulator in select adolescents.
— Stimulants (methylphenidate) effective but start low, go slow; rule out OSA and hypothyroidism first since they mimic ADHD.
— Polyethylene glycol after ruling out Hirschsprung; ensure adequate fiber and hydration.
— Cholinesterase inhibitors (donepezil) and memantine have limited but reasonable trial evidence; treat depression, OSA, hypothyroidism first.

— Complete AVSD repair by 3–6 months of age to prevent fixed pulmonary vascular disease (Eisenmenger physiology develops faster in DS than in non-DS children).
— VSD/ASD/PDA closure timed by hemodynamic significance.
— Pre-op: dental clearance, immunization update, RSV prophylaxis in season, optimize nutrition.
— Post-op endocarditis prophylaxis for 6 months or while residual defect/prosthetic material exists.
— Duodenal atresia repair (duodenoduodenostomy), Hirschsprung pull-through, imperforate anus repair, TEF repair — coordinate with cardiac status before anesthesia.
— Myringotomy with tubes for recurrent effusions/conductive loss.
— Adenotonsillectomy for OSA — counsel families that residual OSA after T&A is common in DS (up to 50%) and a post-op PSG in 6–12 weeks is standard.
— Symptomatic atlantoaxial instability → cervical MRI/flexion-extension films → neurosurgical decompression/fusion.
— Hip dysplasia, slipped capital femoral epiphysis, patellar instability — orthopedic referral.
— Atlantoaxial instability → avoid neck hyperextension during intubation; consider awake fiberoptic or video laryngoscopy.
— Smaller subglottic diameter → use smaller ETT than predicted by age.
— Bradycardia with inhalational induction is common — be ready with atropine.
— Screen for pulmonary HTN pre-op in any child with unrepaired CHD or severe OSA.

— Mitral and aortic valve disease (mitral valve prolapse, aortic regurgitation) develops in adulthood even without congenital heart disease — get a baseline adult echocardiogram at transition (~18–21 yr).
— Pulmonary HTN from chronic OSA or unrepaired shunts.
— Obesity, type 2 diabetes, hyperlipidemia — screen lipids at age 20 and every 5 years, A1c per ADA risk-based criteria, lower threshold given sedentary risk.
— Osteopenia/osteoporosis earlier than general population — DEXA at age 30 in select patients.
— Decreased solid tumor risk overall; increased testicular germ cell tumor risk in men — perform annual testicular exam.
— Continue annual CBC; new cytopenias warrant prompt hematology referral.
— Alzheimer disease: clinical dementia in ~50–70% by age 60. Establish a baseline adult cognitive/adaptive assessment around age 30 as a comparator. Annual screening from age 40 using DS-specific tools (NTG-EDSD, DSQIID).
— Late-onset seizures may be the first sign of Alzheimer disease in DS.

— Offer all pregnant patients (not just advanced maternal age) both screening and diagnostic options per ACOG.
— cfDNA preferred screen ≥10 weeks; positive screen → confirmatory CVS or amniocentesis.
— Provide balanced, non-directive counseling including continuation, adoption, and termination; connect with parent peer groups and the Down syndrome diagnosis network.
— Plan delivery at a center with NICU and pediatric cardiology if prenatally diagnosed.
— High-risk OB management; ~50% transmission of T21; increased risk of preeclampsia, preterm birth; cardiac and thyroid status optimization preconception.
— Normal pubertal development in females; sexual health and consent education in developmentally appropriate language.
— Menstrual hygiene support; contraception decisions involve patient, family, and capacity assessment.
— Sexual abuse risk is 4–10× higher in individuals with intellectual disability — screen routinely and sensitively.
— Begin transition planning at age 14; complete by 21.
— Establish medical guardianship or supported decision-making before age 18 if indicated; address Social Security disability (SSI), Medicaid waivers, vocational training, special needs trusts.
— Identify an adult primary care clinician comfortable with DS surveillance; send a written transition summary including baseline cognition, comorbidities, and surveillance schedule.

— Unrepaired or late-repaired shunts → Eisenmenger syndrome (irreversible pulmonary vascular disease, cyanosis, polycythemia).
— Acquired valvular disease in adulthood.
— Endocarditis risk with residual prosthetic material.
— Recurrent pneumonia, aspiration from hypotonia and GERD.
— Chronic OSA → pulmonary HTN, cor pulmonale, cognitive decline, behavioral problems, growth failure.
— Hypothyroidism (congenital and acquired autoimmune).
— Type 1 diabetes increased ~4×; type 2 diabetes from obesity.
— Transient abnormal myelopoiesis (TAM) in neonates: typically resolves but 20–30% develop AMKL by age 4.
— ALL and AMKL lifetime increased.
— Iron deficiency anemia from picky eating and celiac disease.
— Celiac disease (5–15%), GERD, constipation, Hirschsprung-associated enterocolitis post-repair.
— Symptomatic atlantoaxial instability (rare but catastrophic if missed).
— Seizures (infantile spasms in infancy, late-onset seizures in adults often signaling Alzheimer disease).
— Early-onset Alzheimer disease.

— Any newborn with DS (within first month).
— Murmur, cyanosis, poor feeding, tachypnea, failure to thrive, diaphoresis with feeds.
— Bilious emesis, abdominal distention, failure to pass meconium, imperforate anus — neonatal surgery.
— Symptomatic atlantoaxial instability → neurosurgery and immobilization.
— Neonatal blasts on smear, unexplained cytopenias, organomegaly, persistent leukocytosis — evaluate for TAM/AMKL/ALL.
— Polycythemia with Hct >65% in symptomatic neonate → partial exchange transfusion.
— PSG positive for moderate–severe OSA → ENT for adenotonsillectomy and pulmonology if pulmonary HTN suspected.
— Persistent TSH abnormality, growth deceleration, diabetes management complexity.
— All translocation cases for parental karyotype and recurrence-risk counseling.
— Mosaic cases for prognostic counseling.
— Behavioral regression, suspected ASD, depression, suicidality.
— Pneumonia with hypoxemia (lower threshold given CHD/OSA risk).
— Dehydration with electrolyte derangement.
— Pre-op admission for cardiac surgery or major procedures.
— Acute neurologic change (seizure, focal deficit, suspected cord compression).

— Clenched fists with overlapping fingers, rocker-bottom feet, microcephaly, micrognathia, prominent occiput, severe IUGR.
— VSD, ASD, PDA, omphalocele; >90% mortality in first year; surveillance approach is comfort-focused.
— Holoprosencephaly, cleft lip/palate, polydactyly, microphthalmia, scalp cutis aplasia, severe CHD.
— Similarly high early mortality.
— Female with short stature, webbed neck, low hairline, coarctation of aorta and bicuspid aortic valve, primary amenorrhea, streak ovaries, lymphedema. Normal intelligence (unlike DS).
— Tall stature, gynecomastia, small testes, infertility, mild learning disability. Phenotype emerges in adolescence, not infancy.
— Same trisomy 21 cytogenetic event but only a fraction of cells affected; phenotype variable but don't over-promise mild course — IQ and comorbidity distributions overlap significantly with full trisomy.
— Phenotypically identical to nondisjunction DS but recurrence risk is elevated; parental karyotyping is mandatory.

— Prader-Willi syndrome: neonatal hypotonia, poor feeding, then hyperphagia/obesity, hypogonadism, characteristic facies; chr 15q11-q13 imprinting.
— Spinal muscular atrophy (SMA): profound weakness with tongue fasciculations, areflexia, frog-leg posture; SMN1 deletion. Cognition preserved.
— Congenital myotonic dystrophy: mother with myotonia, polyhydramnios, clubfeet, facial diplegia.
— Zellweger spectrum: dysmorphic, seizures, hepatomegaly, very long chain fatty acids elevated.
— Macroglossia, umbilical hernia, hypotonia, prolonged jaundice, constipation — can phenocopy DS in newborn. Newborn screen catches it; DS infants must still have separate karyotype.
— Short palpebral fissures, smooth philtrum, thin upper lip, microcephaly, developmental delay; history of prenatal alcohol exposure.
— Consider chromosomal microarray, fragile X testing, Rett (in females), Angelman, Williams (elfin facies, supravalvular AS, hypercalcemia, "cocktail party" personality).

— Routine pediatric schedule on time.
— Annual influenza from 6 months.
— RSV prophylaxis (nirsevimab) per current AAP/CDC criteria — DS with hemodynamically significant CHD qualifies as high-risk.
— Pneumococcal: PCV per schedule; consider PPSV23 at age 2 and again at 5 in children with chronic cardiac/pulmonary disease.
— COVID-19 per current recommendations — adults with DS have substantially elevated COVID-19 mortality and are a priority population.
— HPV at 9–12 yr, MenACWY and MenB per schedule.
— DS-specific growth charts; counsel against excess calorie intake from early childhood.
— Daily physical activity 60 min; structured sports with cervical screening if collision risk.
— Dental visits every 6 months from age 2 (high rate of periodontal disease).
— Annual depression and anxiety screening from adolescence.
— Connect families to National Down Syndrome Society, local parent groups, and early intervention/IEP services.
— Special needs trust, ABLE accounts, SSI eligibility, Medicaid waivers, guardianship vs. supported decision-making by age 18.
— Reconcile thyroid, cardiac, psychiatric meds; ensure no anticholinergic burden that could worsen cognition.

— Newborn: 1–2 weeks, then standard well-child schedule (1, 2, 4, 6, 9, 12 mo), often with extra visits for feeding/weight checks.
— Toddler/childhood: every well visit plus subspecialty cadence (cardiology, audiology q6mo, ophtho yearly, dental q6mo).
— Adolescent: annual primary care + mental health + transition planning.
— Adult: annual primary care visit at minimum.
— Growth on DS-specific curves.
— TSH (annual), CBC (annual), lipid panel (every 5 yr in adults).
— Audiology and ophtho dates.
— PSG dates and results.
— Echo dates.
— Cognitive baseline (around age 30) and annual screening from age 40.
— Early intervention (Part C) from diagnosis to age 3: PT, OT, speech.
— School-based services (IEP under IDEA) from age 3.
— Speech therapy especially for articulation given macroglossia and hypotonia.
— Adaptive PE, social skills training, vocational rehab in adolescence.
— Use person-first language ("child with Down syndrome," not "Down's child").
— Emphasize strengths and individual variability; avoid prognostic absolutes.
— Address sibling impact, parental mental health, marital stress.
— Discuss recurrence risk: ~1% above maternal age baseline for nondisjunction; substantially higher for translocation carriers — refer for genetic counseling before next pregnancy.

— Counseling must be non-directive, balanced, and accurate — provide updated outcome data (life expectancy ~60 yr, high rates of community participation) alongside medical realities. Studies show termination rates fall when counseling is comprehensive rather than focused on negatives.
— Offer connection to families raising children with DS and to the Down syndrome diagnosis network during prenatal counseling.
— Most adults with DS have mild–moderate intellectual disability; capacity is decision-specific, not global. A person may consent to a flu shot but need support for surgical consent.
— Default to supported decision-making over plenary guardianship when possible — preserves autonomy and dignity.
— Sexual consent and reproductive decisions require especially careful capacity discussion.
— Individuals with intellectual disability face substantially higher rates of physical, sexual, and financial abuse. Clinicians are mandated reporters; maintain a high index of suspicion for unexplained injuries, behavior change, or caregiver inconsistency. In adults, report to Adult Protective Services.
— 18th birthday cliff: parents lose automatic decision-making authority unless legal planning has occurred — proactively address by age 14–16.
— Pediatric-to-adult transfer: send a structured summary; the adult PCP must own the surveillance schedule going forward.
— Hospital handoffs: communication boards, familiar caregivers at bedside, and explicit accommodation plans reduce error.



High-yield recap bullets:

